Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Salarius Pharmaceuticals Inc. (SLRX)

0.9481   -0.092 (-8.84%) 02-21 16:00
Open: 1.05 Pre. Close: 1.04
High: 1.05 Low: 0.9215
Volume: 728,955 Market Cap: 12M
Salarius Pharmaceuticals, Inc. a clinical-stage oncology company, develops therapies for the treatment of patients with various cancers. The company's lead candidate is Seclidemstat, which is in clinical development for the treatment of Ewing sarcoma, as well as advanced solid tumors, including prostate, breast, and ovarian cancers. It has a collaborative partnership with The Ivy Brain Tumor Center at the Barrow Neurological Institute to to develop cancer treatment for glioblastoma. Salarius Pharmaceuticals, Inc. is headquartered in Houston, Texas.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.051 - 1.056 1.056 - 1.06
Low: 0.909 - 0.914 0.914 - 0.918
Close: 0.942 - 0.95 0.95 - 0.957

Technical analysis

as of: 2020-02-21 4:33:54 PM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 2.62     One year: 3.69
Support: Support1: 0.75    Support2: 0.62
Resistance: Resistance1: 2.24    Resistance2: 3.16
Pivot: 1.36
Moving Average: MA(5): 0.95     MA(20): 1.69
MA(100): 3.74     MA(250): 7.80
MACD: MACD(12,26): -0.62     Signal(9): -0.61
Stochastic oscillator: %K(14,3): 11.13     %D(3): 9.42
RSI: RSI(14): 24.50
52-week: High: 24.45  Low: 0.75  Change(%): -88.5
Average Vol(K): 3-Month: 25531  10-Days: 109835

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
SLRX has closed above bottom band by 34.4%. Bollinger Bands are 80.6% wider than normal. The large width of the bands suggest high volatility as compared to SLRX's normal range. The bands have been in this wide range for 8 bars. This is a sign that the current trend might continue.

Headline News

Fri, 07 Feb 2020 20:54:37 +0000
Health Care Sector Update for 02/07/2020: LGND,ASRT,COLL,SLRX

Fri, 07 Feb 2020 18:42:03 +0000
Health Care Sector Update for 02/07/2020: LGND,ASRT,COLL,SLRX

Mon, 26 Aug 2019 17:41:57 +0000
Health Care Sector Update for 08/26/2019: RKDA, SLRX

Mon, 26 Aug 2019 19:57:35 +0000
Health Care Sector Update for 08/26/2019: AKRX, RKDA, SLRX

Wed, 14 Mar 2018 07:14:36 +0000
5 ‘Strong Buy’ Biotechs That Can Double in 2018

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqCM
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 12.86
Shares Float (M) 2.93
% Held by Insiders 9.26
% Held by Institutions 1.74
Shares Short (K) 106
Shares Short P. Month (K)

Stock Financials

EPS -5.136
Book Value (p.s.) 2.590
PEG Ratio
Profit Margin -200.50
Operating Margin -148.62
Return on Assets (ttm) -27.2
Return on Equity (ttm) -109.7
Qtrly Rev. Growth 86.5
Gross Profit (p.s.) 0.052
Sales Per Share
EBITDA (p.s.) -0.353
Qtrly Earnings Growth
Operating Cash Flow (M) -8.56
Levered Free Cash Flow (M) -2.95

Stock Valuations

P/E -0.18
P/E Growth Ratio -0.09
P/BV 0.37
P/S 0.37
P/CF -1.42

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2019-07-21
Last Split Ratio 0.04
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.